カテゴリ： MarketLine, インド, 企業調査

Bharti Airtel Limited：企業の戦略・SWOT・財務情報

◆英語タイトル：Bharti Airtel Limited - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C6976
◆発行会社（調査会社）：MarketLine
◆発行日：2018年10月
◆ページ数：59
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：インド
◆産業分野：技術・通信
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Bharti Airtel Limited – Strategy, SWOT and Corporate Finance Report
Summary

Bharti Airtel Limited – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Bharti Airtel Limited (Bharti Airtel or ‘the company’) is a global telecommunications company., The company offers second generation (2G,) third generation (3G) and fourth generation (4G) wireless services, mobile commerce, fixed line services, high speed digital subscriber line (DSL) broadband, internet protocol television (IPTV), direct-to-home (DTH), enterprise services including national and international long distance services to carriers. The company caters to various industries including manufacturing and distribution, hospitality, healthcare, government, media and entertainment and education. It also provides video, voice, data, network integration, data center, and managed services, as well as mobile applications and digital media solutions. Bharti Airtel is headquartered in New Delhi, India.

Scope

- Detailed information on Bharti Airtel Limited required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Bharti Airtel Limited in the form of a SWOT analysis
- An in-depth view of the business model of Bharti Airtel Limited including a breakdown and examination of key business segments
- Intelligence on Bharti Airtel Limited’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Bharti Airtel Limited, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Bharti Airtel Limited and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Bharti Airtel Limited as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Bharti Airtel Limited’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Bharti Airtel Limited: Company Overview 9
Bharti Airtel Limited: Overview and Key Facts 9
Bharti Airtel Limited: Overview 9
Bharti Airtel Limited: Key Facts 9
Bharti Airtel Limited: Key Employees 11
Bharti Airtel Limited: Key Employee Biographies 16
Bharti Airtel Limited: Major Products and Services 20
Bharti Airtel Limited: Company History 21
Bharti Airtel Limited: Management Statement 29
Bharti Airtel Limited: Locations and Subsidiaries 31
Bharti Airtel Limited: Key Competitors 32
Bharti Airtel Limited: Company Analysis 33
Bharti Airtel Limited: Business Description 33
Bharti Airtel Limited: SWOT Analysis 35
Bharti Airtel Limited: SWOT Overview 35
Bharti Airtel Limited: Strengths 35
Bharti Airtel Limited: Weaknesses 36
Bharti Airtel Limited: Opportunities 37
Bharti Airtel Limited: Threats 39
Bharti Airtel Limited: Corporate Financial Deals Activity 40
Bharti Airtel Limited: Financial Deals Overview 40
Bharti Airtel Limited: Targets and Partners 42
Bharti Airtel Limited: Top Deals 2014 – 2018YTD* 43
Bharti Airtel Limited: Mergers and Acquisitions 44
Bharti Airtel Limited: Capital Raising 45
Bharti Airtel Limited: Partnership 46
Bharti Airtel Limited: Divestments 47
Bharti Airtel Limited: Private Equity and Ownership 48
Bharti Airtel Limited: Recent Developments 49
Bharti Airtel Limited: News and Events Summary 49
Bharti Airtel Limited: Contracts 53
Bharti Airtel Limited: Corporate Governance 54
Bharti Airtel Limited: IT Spending Announcements 55
Bharti Airtel Limited: Market Developments 56
Appendix 57
Contact Us 57
Methodology 57
About MarketLine 58

List of Tables
Table 1: Bharti Airtel Limited: Key Facts
Table 2: Bharti Airtel Limited: Key Employees
Table 3: Bharti Airtel Limited: Company History
Table 4: Bharti Airtel Limited: Locations and Subsidiaries
Table 5: Bharti Airtel Limited: Key Competitors
Table 6: Bharti Airtel Limited: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Bharti Airtel Limited: M&A Activity by Geography (TTM*)
Table 8: Bharti Airtel Limited: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 9: Bharti Airtel Limited: M&A Average Deal Size - Value (US$m)
Table 10: Bharti Airtel Limited: Targets and Partners
Table 11: Bharti Airtel Limited: Top Deals 2014 - 2018YTD*
Table 12: Bharti Airtel Limited: M&A Volume and Value Trend (2014 - YTD*2018)
Table 13: Bharti Airtel Limited: M&A Activity by Geography (2014 - YTD*2018)
Table 14: Bharti Airtel Limited: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 15: Bharti Airtel Limited: Capital Raising by Deal Type (2014 - YTD*2018)
Table 16: Bharti Airtel Limited: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 17: Bharti Airtel Limited: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 18: Bharti Airtel Limited: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 19: Bharti Airtel Limited: Divestments by Geography (2014 - YTD*2018)
Table 20: Bharti Airtel Limited: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Table 21: Bharti Airtel Limited: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)
Table 22: Bharti Airtel Limited: News and Events Summary
Table 23: Bharti Airtel Limited: Contracts
Table 24: Bharti Airtel Limited: Corporate Governance
Table 25: Bharti Airtel Limited: IT Spending Announcements
Table 26: Bharti Airtel Limited: Market Developments

List of Figures
Figure 1: Bharti Airtel Limited: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Bharti Airtel Limited: M&A Activity by Geography (TTM*)
Figure 3: Bharti Airtel Limited: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: Bharti Airtel Limited: M&A Average Deal Size - Value (US$m)
Figure 5: Bharti Airtel Limited: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 6: Bharti Airtel Limited: M&A Activity by Geography (2014 - YTD*2018)
Figure 7: Bharti Airtel Limited: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 8: Bharti Airtel Limited: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 9: Bharti Airtel Limited: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 10: Bharti Airtel Limited: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 11: Bharti Airtel Limited: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 12: Bharti Airtel Limited: Divestments by Geography (2014 - YTD*2018)
Figure 13: Bharti Airtel Limited: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Figure 14: Bharti Airtel Limited: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Bharti Airtel Limited：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Lannett Company Inc (LCI)：製薬・医療：M&Aディール及び事業提携情報
    Summary Lannett Company Inc (Lannett) is a pharmaceutical company. It develops, manufactures and distributes generic prescription pharmaceutical products in tablet, capsule and oral liquid forms. The company offers generic pharmaceuticals for medical indications such as antibiotic, cardiovascular, c …
  • Nishimatsu Construction Co., Ltd. (1820)：企業の財務・戦略的SWOT分析
    Nishimatsu Construction Co., Ltd. (1820) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • AGL Energy Limited：企業の戦略・SWOT・財務情報
    AGL Energy Limited - Strategy, SWOT and Corporate Finance Report Summary AGL Energy Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Orange SA (ORA)：企業の財務・戦略的SWOT分析
    Orange SA (ORA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Tulip Diagnostics (P) Ltd：医療機器：M&Aディール及び事業提携情報
    Summary Tulip Diagnostics (P) Ltd (Tulip Diagnostics), a subsidiary of Tulip Group is a diagnostic company that manufactures and markets in vitro diagnostic reagents and kits. The company provides assay systems for immunohaematology, hematology, rheumatology, infectious diseases, hemostasis, and ins …
  • Brembo SpA：戦略・SWOT・企業財務分析
    Brembo SpA - Strategy, SWOT and Corporate Finance Report Summary Brembo SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Votorantim SA：企業の戦略的SWOT分析
    Votorantim SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Siemens AG (SIE)：医療機器：M&Aディール及び事業提携情報
    Summary Siemens AG (Siemens) is a technology company that offers products and solutions for electrification, automation and digitization. The company offers products, services and solutions for power generation, transmission and distribution; oil and gas production and transportation; medical imagin …
  • Autoliv Inc (ALV)：企業の財務・戦略的SWOT分析
    Autoliv Inc (ALV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Societatea Nationala Nuclearelectrica SA (SNN)-エネルギー分野：企業M&A・提携分析
    Summary Societatea Nationala Nuclearelectrica S.A. (SNN) is a state owned power generating company. It generates nuclear power and heat using nuclear fission and also manufactures nuclear fuel. SNN is the only company producing electricity based on nuclear technology in Romania. It also produces nuc …
  • Isto Biologics-医療機器分野：企業M&A・提携分析
    Summary Isto Biologics (Isto), formerly ISTO Technologies Inc, is an orthobiologics company which manufactures and develops products to treat orthopedic and spine disorders. The company offers solutions in cell therapy and rapid bone healing. Its product portfolio includes InQu, a bone graft extende …
  • Biogen Inc (BIIB)：医療機器：M&Aディール及び事業提携情報
    Summary Biogen Inc (Biogen) is a global biopharmaceutical company that discovers, develops and delivers drugs for the treatment of neurological and neurodegenerative diseases worldwide. The company’s marketed products include Avonex (interferon beta-1a), Tysabri (natalizumab), Tecfidera (dimethyl fu …
  • Max-Delbruck-Centrum fur Molekulare Medizin (MDC)-製薬・医療分野：企業M&A・提携分析
    Summary Max-Delbruck-Centrum fur Molekulare Medizin (MDC) is a biomedical research centre. The centre offers molecular biology research services, signal transduction research, development biology research, molecular immunology and gene therapy research, non coding RNAs research, cytoplasmic gene reg …
  • Ceres Power Holdings plc (CWR)：企業の財務・戦略的SWOT分析
    Summary Ceres Power Holdings Plc (Ceres Power) operates as an alternative energy company that develops low cost and next generation fuel cell technologies. The company carries out developing steel cell a fuel cell technology that converts natural gas and hydrogen fuel directly into electrical power …
  • Agilysys Inc (AGYS)：企業の財務・戦略的SWOT分析
    Agilysys Inc (AGYS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Taiho Pharmaceutical Co Ltd-製薬・医療分野：企業M&A・提携分析
    Summary Taiho Pharmaceutical Co Ltd (Taiho), a subsidiary of Otsuka Group focuses on the development, production and marketing of pharmaceutical products in the fields of cancer, allergy, immunology, urology and others. Its product portfolio includes pharmaceutical products such as anti-allergic age …
  • Green Earth Technologies Inc (GETG)：企業の財務・戦略的SWOT分析
    Summary Green Earth Technologies Inc (GET) is a clean technology company that develops and markets of bio-based performance and cleaning products. The company’s products include small engine oils, motor oils, lubrication and engine protection oils. It also provides wheel cleaner, hydrophobic car was …
  • Saab AB：企業の戦略・SWOT・財務情報
    Saab AB - Strategy, SWOT and Corporate Finance Report Summary Saab AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • ProMIS Neurosciences Inc (PMN)：医療機器：M&Aディール及び事業提携情報
    Summary ProMIS Neurosciences Inc (ProMIS), formerly Amorfix Life Sciences Ltd is a development stage biopharmaceutical company which focuses on the development of therapeutic antibodies and diagnostics for the treatment of misfolded protein diseases. The company uses ProMIS technology, helps in pred …
  • Cutera Inc (CUTR)：企業の財務・戦略的SWOT分析
    Cutera Inc (CUTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆